Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Torsten Kuwert

Showing results (141-150 of 172) with videos related to

Pageof 18
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|August 3, 2012
Induction and repair of DNA double-strand breaks in blood lymphocytes of patients undergoing ¹⁸F-FDG PET/CT examinationsMatthias S May, Michael Brand, Wolfgang Wuest, et al.
Nuklearmedizin. Nuclear Medicine|June 29, 2022
Standardized 18F-FDG PET/CT radiomic features provide information on PD-L1 expression status in treatment-naïve patients with non-small cell lung cancerRuiyun Zhang, Wolfgang Hohenforst-Schmidt, Claus Steppert, et al.
RMD Open|November 28, 2025
Synovial fibroblast activation occurs before the onset of rheumatoid arthritis and influences the risk of developing diseaseArmin Atzinger, Koray Tascilar, Arnd Kleyer, et al.
Clinical Nuclear Medicine|February 6, 2018
SPECT/CT With the PSMA Ligand 99mTc-MIP-1404 for Whole-Body Primary Staging of Patients With Prostate CancerChristian Schmidkonz, Michael Cordes, Michael Beck, et al.
Thyroid : Official Journal of the American Thyroid Association|May 17, 2011
Effects of recombinant human thyroid-stimulating hormone superagonists on thyroidal uptake of 18F-fluorodeoxyglucose and radioiodideJulia Reinfelder, Simone Maschauer, Catherine A Foss, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 5, 2018
<sup>68</sup>Ga-PSMA-11 PET/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancerChristian Schmidkonz, Michael Cordes, Daniela Schmidt, et al.
Frontiers in Oncology|January 25, 2021
The Distribution of Pelvic Nodal Metastases in Prostate Cancer Reveals Potential to Advance and Personalize Pelvic RadiotherapyIrina Filimonova, Daniela Schmidt, Sina Mansoorian, et al.
Clinical Nuclear Medicine|June 20, 2018
Assessment of Treatment Response by 99mTc-MIP-1404 SPECT/CT: A Pilot Study in Patients With Metastatic Prostate CancerChristian Schmidkonz, Michael Cordes, Michael Beck, et al.
Rheumatology (Oxford, England)|July 11, 2023
Rescue therapy of antisynthetase syndrome with CD19-targeted CAR-T cells after failure of several B-cell depleting antibodiesJule Taubmann, Johannes Knitza, Fabian Müller, et al.
Frontiers in Nuclear Medicine|October 2, 2024
Cyclotrons Operated for Nuclear Medicine and Radiopharmacy in the German Speaking D-A-CH Countries: An Update on Current Status and TrendsClaus Zippel, Johannes Ermert, Marianne Patt, et al.
Pageof 18

Showing results (141-150 of 172) with videos related to

Sort By:
Pageof 18
European Journal of Nuclear Medicine and Molecular Imaging|August 3, 2012
Induction and repair of DNA double-strand breaks in blood lymphocytes of patients undergoing ¹⁸F-FDG PET/CT examinationsMatthias S May, Michael Brand, Wolfgang Wuest, et al.
Nuklearmedizin. Nuclear Medicine|June 29, 2022
Standardized 18F-FDG PET/CT radiomic features provide information on PD-L1 expression status in treatment-naïve patients with non-small cell lung cancerRuiyun Zhang, Wolfgang Hohenforst-Schmidt, Claus Steppert, et al.
RMD Open|November 28, 2025
Synovial fibroblast activation occurs before the onset of rheumatoid arthritis and influences the risk of developing diseaseArmin Atzinger, Koray Tascilar, Arnd Kleyer, et al.
Clinical Nuclear Medicine|February 6, 2018
SPECT/CT With the PSMA Ligand 99mTc-MIP-1404 for Whole-Body Primary Staging of Patients With Prostate CancerChristian Schmidkonz, Michael Cordes, Michael Beck, et al.
Thyroid : Official Journal of the American Thyroid Association|May 17, 2011
Effects of recombinant human thyroid-stimulating hormone superagonists on thyroidal uptake of 18F-fluorodeoxyglucose and radioiodideJulia Reinfelder, Simone Maschauer, Catherine A Foss, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 5, 2018
<sup>68</sup>Ga-PSMA-11 PET/CT-derived metabolic parameters for determination of whole-body tumor burden and treatment response in prostate cancerChristian Schmidkonz, Michael Cordes, Daniela Schmidt, et al.
Frontiers in Oncology|January 25, 2021
The Distribution of Pelvic Nodal Metastases in Prostate Cancer Reveals Potential to Advance and Personalize Pelvic RadiotherapyIrina Filimonova, Daniela Schmidt, Sina Mansoorian, et al.
Clinical Nuclear Medicine|June 20, 2018
Assessment of Treatment Response by 99mTc-MIP-1404 SPECT/CT: A Pilot Study in Patients With Metastatic Prostate CancerChristian Schmidkonz, Michael Cordes, Michael Beck, et al.
Rheumatology (Oxford, England)|July 11, 2023
Rescue therapy of antisynthetase syndrome with CD19-targeted CAR-T cells after failure of several B-cell depleting antibodiesJule Taubmann, Johannes Knitza, Fabian Müller, et al.
Frontiers in Nuclear Medicine|October 2, 2024
Cyclotrons Operated for Nuclear Medicine and Radiopharmacy in the German Speaking D-A-CH Countries: An Update on Current Status and TrendsClaus Zippel, Johannes Ermert, Marianne Patt, et al.
Pageof 18